Sign in
4

Changes in Ownership

Hims & Hers Health, Inc. Filed Acc 0001773751-25-000124

Chief Executive Officer sold 83,994 shares at an average $28.15 ($2,364,547)

  • Chief Executive Officer acquired 33,668 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Dudum Andrew Chief Executive Officer 2025-04-16 Option exercise 10b5-1 +17,001 $2.43 $41,312 111,896 D: show line 1 in the form
Dudum Andrew Chief Executive Officer 2025-04-16 Option exercise 10b5-1 +16,667 $2.43 $40,501 128,563 D: show line 2 in the form
Dudum Andrew Chief Executive Officer 2025-04-16 Sale 10b5-1 −33,668 $28.02 $943,421 94,895 D: show line 3 in the form
Dudum Andrew Chief Executive Officer 2025-04-16 Sale 10b5-1 −2,792 $28.31 $79,032 92,103 D: show line 4 in the form
Dudum Andrew Chief Executive Officer 2025-04-16 Sale 10b5-1 −47,534 $28.23 $1,342,094 332,728 I: show line 5 in the form
Open-market sales · 83,994 sh · avg $28.15 · $2,364,547

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Dudum Andrew Chief Executive Officer 2025-04-16 Option exercise · Stock Option (right to buy) 10b5-1 −17,001 119,011 D: show line 6 in the form
Dudum Andrew Chief Executive Officer 2025-04-16 Option exercise · Stock Option (right to buy) 10b5-1 −16,667 1,173,066 D: show line 7 in the form
Loading xslF345X05/wk-form4_1745005205.xml…